Antibodies to the HIV envelope protein (Env, consisting of the precursor gp160, external domain gp120, and transmembrane domain gp41) provide the neutralizing components necessary for an effective AIDS vaccine [1]–[3]. The gene discussed is ERVW-1; the disease is AIDS.